foxo4-dri peptide human clinical trial

foxo4-dri peptide human clinical trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI (10mg) – True Lab

Name: foxo4-dri peptide human clinical trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI (10mg) – True Lab
Brand: cantondelareina.com.ar
SKU: 70416032544
Price: 29.19 USD
Availability: InStock
Rating: 4.8676 (8 reviews)

FOXO4 DRI (10mg) True Lab Peptides FOXO4 DRI 10mg FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress

SKU: 70416032544 · From cantondelareina.com.ar

4.9

USD29.19 USD65.19

Pay in 4 interest-free payments of $7.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

Description

Further experiments have demonstrated that the peptide is capable of suppressing the activity of pro-inflammatory and fibrotic factors characteristic of the senescence-associated secretory phenotype (SASP), thereby contributing to the restoration of damaged tissue microenvironments